Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, host Sarah Hughan tells all on Blinklab’s (ASX:BB1) step towards FDA approval for its autism diagnostic app after receiving certain confirmation from the US food and drug administration.

According to the country’s CDC, 1 in 36 children in America have autism spectrum disorder. 

Tune in to get the latest.

 

While BlinkLab is a Stockhead advertiser, it did not sponsor this content.

Read MoreHealthMedtech

Featured Companies

You might be interested in